Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
2276
Ellington Financial
EFC
$1.69B
| $269K | ﹤0.01% |
22,799
+60
| +0.3% | +$721 |
|
2277
Toast
TOST
$19.1B
| $268K | ﹤0.01% |
10,776
+76
| +0.7% | +$1.57K |
|
2278
Sinclair Inc
SBGI
$994M
| $268K | ﹤0.01% |
19,918
+2
| +0% | +$29 |
|
2279
Ezcorp Inc
EZPW
$1.79B
| $268K | ﹤0.01% |
23,632
| – | – |
|
2280
Yext
YEXT
$552M
| $267K | ﹤0.01% |
44,382
| – | – |
|
|
TRML
2281
DELISTED
Tourmaline Bio
TRML
| $266K | ﹤0.01% |
+11,593
| New | +$409K |
|
|
HTB
2282
HomeTrust Bancshares
HTB
$860M
| $265K | ﹤0.01% |
9,680
-980
| -9% | -$25.7K |
|
2283
Corsair Gaming
CRSR
$1.14B
| $263K | ﹤0.01% |
21,391
+2
| +0% | +$26 |
|
|
VMEO
2284
DELISTED
Vimeo
VMEO
| $262K | ﹤0.01% |
64,141
+8
| +0% | +$34 |
|
2285
Mercantile Bank Corp
MBWM
$1.03B
| $262K | ﹤0.01% |
6,819
+1
| +0% | +$38 |
|
2286
Pliant Therapeutics
PLRX
$65.6M
| $261K | ﹤0.01% |
17,526
+1
| +0% | +$16 |
|
2287
ChargePoint
CHPT
$142M
| $260K | ﹤0.01% |
6,837
+14
| +0.2% | +$549 |
|
|
GLDD
2288
DELISTED
Great Lakes Dredge & Dock
GLDD
| $258K | ﹤0.01% |
29,518
+3
| +0% | +$25 |
|
2289
Treace Medical Concepts
TMCI
$284M
| $258K | ﹤0.01% |
19,779
+3
| +0% | +$40 |
|
2290
Astronics
ATRO
$3.38B
| $258K | ﹤0.01% |
16,248
+8
| +0% | +$119 |
|
|
CATC
2291
DELISTED
CAMBRIDGE BANCORP
CATC
| $257K | ﹤0.01% |
3,789
+1
| +0% | +$66 |
|
2292
Liberty Latin America Class A
LILA
$1.63B
| $257K | ﹤0.01% |
54,158
-19
| -0% | -$87 |
|
2293
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.74B
| $257K | ﹤0.01% |
5,688
+187
| +3% | +$8.45K |
|
2294
AMC Entertainment Holdings
AMC
$2.47B
| $256K | ﹤0.01% |
68,737
+284
| +0.4% | +$1.26K |
|
2295
Pangaea Logistics
PANL
$493M
| $256K | ﹤0.01% |
+36,726
| New | +$301K |
|
2296
Conduent
CNDT
$245M
| $256K | ﹤0.01% |
75,987
+4
| +0% | +$14 |
|
2297
Great Southern Bancorp
GSBC
$872M
| $254K | ﹤0.01% |
4,644
| – | – |
|
2298
NRC Health Common Stock
NRC
$419M
| $254K | ﹤0.01% |
6,428
+4
| +0.1% | +$158 |
|
2299
Scholar Rock
SRRK
$5.87B
| $254K | ﹤0.01% |
14,328
+7
| +0% | +$110 |
|
2300
Amerant Bancorp
AMTB
$1.16B
| $253K | ﹤0.01% |
10,877
| – | – |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.